tiprankstipranks
Trending News
More News >
Nurix Therapeutics (NRIX)
NASDAQ:NRIX
US Market
Advertisement

Nurix Therapeutics (NRIX) Revenue

Compare
454 Followers

Nurix Therapeutics Revenue

Nurix Therapeutics had a revenue of 44.06M in the quarter ending Jun 30, 2025, with 138.75%. This bring the company's revenue in the last twelve months to 9.23M, Increased -16.78%. In the fiscal year ending Dec 31, 2024, Nurix Therapeutics had annual revenue of 54.55M with -29.15% growth.
Revenue (ttm)
9.23M
Revenue Growth
41.86%
P/S Ratio
13.79
Revenue/Employee
$190,731
Employees
286
Market Cap
$752.26M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
54.55M-22.44M-29.15%
Dec 31, 2023
76.99M38.36M+99.31%
Dec 31, 2022
38.63M8.88M+29.84%
Dec 31, 2021
29.75M11.93M+66.95%
Dec 31, 2020
17.82M-13.29M-42.73%
Dec 31, 2019
31.11M-6.33M-16.91%
Dec 31, 2018
37.45M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis